DNA Nanotechnology Market is expected to grow at a CAGR of 21.56% through 2031
Global DNA Nanotechnology
Market is driven by evolving applications of nano-medical
devices in the forecast period, 2027-2031.
According to TechSci Research report, “DNA
Nanotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity
and Forecast, 2021-2031”, the Global DNA Nanotechnology Market will grow from USD 5.91 Billion in 2025 to USD 19.07 Billion by 2031 at a 21.56% CAGR.
The increasing use of targeted drug delivery is further driving growth in the global DNA nanotechnology market over the next five years. The growing prevalence of cancer, genetic diseases, and cardiovascular diseases further substantiates the growth of the global DNA nanotechnology market in the next five years.
Also, technological advancement and innovative product development
through nanoscale technologies for effective diagnosis further supports the
growth of the global DNA nanotechnology market in the forecast period. Additionally, the rising demand for personalized and genetic medicine is expected to drive growth in the global DNA nanotechnology market over the forecast
period.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global DNA Nanotechnology Market"
https://www.techsciresearch.com/report/dna-nanotechnology-market/8174.html
The global DNA nanotechnology market is segmented by type, application, end user, region, and competitive landscape. Based on application, the market is segmented into targeted drug delivery, smart pills, nanolithography, and other applications. Targeted drug delivery is expected to account for the largest share of the market and dominate the market segment over the next five years, driven by increasing demand for efficient delivery to targeted organs.
Also, increasing instances of cancer and targeted drug delivery system
for cell apoptosis to remove tumor caused by cancerous cells is also expected
to substantiate the growth of the global DNA nanotechnology market in the
forecast years. Smart pills are also expected to register significant growth in
the future five years on account of increasing demand for personalized medicine
and nanomedicine. Smart pills are pill-shaped but perform advanced functions such as sensing, imaging, and drug delivery.
Based on end user, the market is segmented into biotechnology &
pharmaceutical companies, academic & research institutions, and others.
Biotechnology and pharmaceutical companies are anticipated to hold the most significant revenue shares of the market and dominate the market segment in the upcoming
five years on account of increasing adoption of DNA nanotechnology in
pharmaceutical products.
Additionally, the continued advancement of nanomedicine is expected to support growth in this sub-segment further and, consequently, the global DNA nanotechnology market over the next five years. Academic & research institutions
are also anticipated to register significant growth in the future five years on
account of increasing research and development of pharmaceuticals,
therapeutics, and medical devices with the use of nano-technology and thus
support the growth of the global DNA nanotechnology market in the forecast
years, until 2027F.
Some of the market players, dominating the global DNA nanotechnology market
are:
·
NuProbe USA Inc.
·
tilibit nanosystems GmbH
·
GATTAquant GmbH
·
Genisphere LLC
·
Inovio Pharmaceuticals, Inc.
·
Novartis International AG
The existing market players
are highly invested in research and product development along with viable
service provisions for the consumers. New market entrants may follow similar
strategies along with mergers and acquisitions for future brand establishment.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=8174
Customers can also request for 10% free customization on this report.
“North America is anticipated to dominate the market and hold
largest revenue shares of the market in the upcoming five years. The growth of
the region can be attributed to the factors like rapidly increasing
technological advancement along with applications of technology in diagnosis of
various diseases, effective treatment and efficient preventive measures taken
in the United States. Moreover, increased investment from government authorities and private investors, including pharmaceutical companies and healthcare investors, is expected further to support the growth of the global DNA nanotechnology market. Additionally, increasing cardiovascular diseases in
the countries like the US is also substantiating the growth of the global DNA
nanotechnology market. Demand for the nano-medical devices and DNA
nanotechnology for the targeted drug delivery to the CVD patients further aids
the growth of the global DNA nanotechnology market in the forecast years,” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“DNA Nanotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, Segmented By Type (Structural DNA Nanotechnology {Extended Lattices, Discrete Structures, Templated Assembly} v/s Dynamic DNA Nanotechnology {Nanomechanical Devices v/s Strand Displacement Cascades}), By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region 2021-2031F”, has evaluated
the future growth potential of global DNA nanotechnology market and provides
statistics & information on market size, structure and future market
growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. The report also identifies and analyzes emerging trends, essential drivers,
challenges, and opportunities in the global DNA nanotechnology market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/